VICENTE
MOLINA RODRIGUEZ
CATEDRATICOS DE UNIVERSIDAD
Tomás
Palomo Alvarez
Publicaciones en las que colabora con Tomás Palomo Alvarez (28)
2016
-
Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients
European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 8, pp. 743-753
2013
-
Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year
Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161
2009
-
Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia
Psychiatry Research - Neuroimaging, Vol. 173, Núm. 2, pp. 88-93
2008
-
Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 1, pp. 257-266
-
Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)
Genes, Brain and Behavior, Vol. 7, Núm. 7, pp. 796-801
2007
-
Changes in cortical volume with olanzapine in chronic schizophrenia
Pharmacopsychiatry, Vol. 40, Núm. 4, pp. 135-139
-
Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder
European Psychiatry, Vol. 22, Núm. 8, pp. 505-512
-
Effect of interleukin-1β gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 144, Núm. 8, pp. 1090-1093
-
Marked hypofrontality in clozapine-responsive patients
Pharmacopsychiatry, Vol. 40, Núm. 4, pp. 157-162
-
No association between dorsolateral prefrontal gray matter deficit and N-acetyl aspartate ratios in schizophrenia
Neuropsychobiology, Vol. 54, Núm. 3, pp. 171-178
2006
-
Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia
European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, Núm. 2, pp. 106-111
2005
-
Association between excessive frontal cerebrospinal fluid and illness duration in males but not in females with schizophrenia
European Psychiatry, Vol. 20, Núm. 4, pp. 332-338
-
Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement
Psychopharmacology, Vol. 178, Núm. 1, pp. 17-26
-
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia
Schizophrenia Research, Vol. 80, Núm. 1, pp. 61-71
-
N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration
Schizophrenia Research, Vol. 73, Núm. 2-3, pp. 209-219
-
Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia
International Clinical Psychopharmacology, Vol. 20, Núm. 1, pp. 13-18
-
Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity
Journal of Psychiatric Research, Vol. 39, Núm. 2, pp. 117-127
-
Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene
NeuroImage, Vol. 27, Núm. 4, pp. 1002-1006
2004
-
Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia
International Clinical Psychopharmacology, Vol. 19, Núm. 4, pp. 221-228
-
Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients
Psychiatry Research - Neuroimaging, Vol. 131, Núm. 1, pp. 45-56